Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

cyclopia sequence 8Neoplasms, Plasma Cell 2Multiple Myeloma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Hypesthesia 1Head and Neck Neoplasms 1Exanthema 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Anxiety Disorders 1Acute Pain 1

Interventions

Bevacizumab 234Fluorouracil 220Oxaliplatin 216Irinotecan 215Leucovorin 199Capecitabine 153Cetuximab 146Panitumumab 70Folfox protocol 51regorafenib 43Radiotherapy 38pembrolizumab 37IFL protocol 36HMPL-013 36trifluridine tipiracil drug combination 32Nivolumab 32Drug Therapy 26Neoadjuvant Therapy 24Trifluridine 18Celecoxib 18tislelizumab 17XELOX 17sintilimab 16Trastuzumab 16durvalumab 15atezolizumab 15aflibercept 15Chemotherapy, Adjuvant 15Biopsy 15apatinib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Colorectal Neoplasms × Minocycline × Clear all
NCT01906008 2020-03-17

Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients

M.D. Anderson Cancer Center

Phase 2 Completed
122 enrolled 9 charts
Gastrointestinal

cyclopia sequence, Hypesthesia, Pain, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡